|
|
Сonditions and diseases
AIDS/HIV ALS Alzheimer's Disease Anemia Anti-Aging Treatment Arterial Hypertension Autism Cancer Diabetes Treatment Eye Diseases Idiopathic Encephalopathy Ischemic Heart Disease Liver Diseases MD Treatment Multiple Sclerosis Treatment Parkinson Treatment Rheumatoid Arthritis SMA Ulcerative Colitis. Crohn’s Disease
News about stem cells
Stem cell treatment protects bone marrow from damaging chemotherapy effects in cancer patients
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
New Approach to Treating Muscular Dystrophy With Stem Cells
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
A New Brain Stem Cell Discovered
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
All news
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
Experience in Treatment of Patients Suffering From Diabetes Mellitus with the Use of Fetal Stem Cells
Smikodub A.I., Novitskaya A.V., Yefimov A.S.
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center EmCell
Prescriptions for treatment of patients suffering from diabetes mellitus with the use of fetal cell suspensions (FCS) containing hematopoietic stem cells have been based on the experience gained through treatment of 56 patients.
In patients who received fetal stem cell treatment were noted:
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center EmCell
Prescriptions for treatment of patients suffering from diabetes mellitus with the use of fetal cell suspensions (FCS) containing hematopoietic stem cells have been based on the experience gained through treatment of 56 patients.
In patients who received fetal stem cell treatment were noted:
- Syndrome of early post transplantation improvement of general state consisting in a decrease of weakness, restoration of ability to work, appetite and sleep. It was observed in 63% cases. It is clearly expressed during a month.
- Syndrome of psychophysiological changes, consisting in the improvement of physical and intellectual capabilities, of mood, increasing of general activity and vitality, has been noted in 48% cases (lasts for 6-8 months).
- Restoration of immune indices: increase in amounts of lymphocytes, T-lymphocytes and subpopulations of T-lymphocytes, decrease in the amount of B-lymphocytes 30% to 60%. The duration of this phenomenon ranged 3 to 8 months.
- Decrease in the level of glycemia in patients suffering from initially revealed insulin-dependent diabetes mellitus. In 100% cases, the dosage of administered insulin after transplantation gradually decreased over the next 2 to 3 months. The average initial dosage of insulin was 0.76±0.06 units/kg/day. Decrease equaled 20-100% of the initial dosage (41% on average). In 65% cases, clinical remission of the disease was developed. Duration of remission was 5 to 14 months.
- Restoration of hemopoiesis in patients suffering from glomerulosclerosis complicated by chronic renal insufficiency and anemic syndrome.